| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |